secwatch.observer — SEC 8-K summary
======================================

Issuer:     FITLIFE BRANDS, INC. (FTLF)
CIK:        0001374328
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001437749-25-009584
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FitLife Q4 rev +13% to $15M; FY24 adj EBITDA +39% to $14.1M; Q1 2025 rev seen -4-6%
--------------------------------------------------------------------------------

- Q4 2024 revenue $15.0M (+13% YoY), net income $2.1M ($0.21 diluted EPS), adjusted EBITDA $3.1M (+31%).
- FY24 revenue $64.5M (+22%), net income $9.0M (+70%), adj EBITDA $14.1M (+39%); net debt $8.6M (0.6x adj EBITDA).
- GNC commercial dispute settled Jan 2025; Legacy FitLife Q4 wholesale down 20% due to order halt, now selling directly to franchisees.
- MusclePharm Q4 revenue $2.8M (+14% seq); launched Pro Series at Vitamin Shoppe and new RTD protein; rebranding underway.
- Q1 2025 prelim: revenue down 4-6% YoY (MRC seasonality, leap year), adj EBITDA flat; China tariffs may raise COGS, mitigating via raw material stockpiling.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/0001437749-25-009584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/ftlf20250327_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-009584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer